Common use of Status as Stockholder Clause in Contracts

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Non-Voting Preferred Stock. In no event shall the Series A Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 5 contracts

Sources: Merger Agreement (Spyre Therapeutics, Inc.), Merger Agreement (Aeglea BioTherapeutics, Inc.), Merger Agreement (Aeglea BioTherapeutics, Inc.)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Non-Voting Preferred Stock. In no event shall the Series A Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 2 contracts

Sources: Agreement and Plan of Merger and Reorganization (Glycomimetics Inc), Merger Agreement (Aerovate Therapeutics, Inc.)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A Non-Voting X1 Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A Non-Voting X1 Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Non-Voting X1 Preferred Stock. In no event shall the Series A Non-Voting X1 Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Merger Agreement (Novus Therapeutics, Inc.)

Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series Class A Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series Class A Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates (or book entry notations) for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series Class A Non-Voting Preferred Stock. In no event shall the Series A Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Securities Purchase Agreement (Fate Therapeutics Inc)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A C Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A C Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A C Non-Voting Preferred Stock. In no event shall the Series A C Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Merger Agreement (Traws Pharma, Inc.)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Non-Voting Preferred Stock. In no event shall the Series A Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Merger Agreement (Unum Therapeutics Inc.)

Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series A Non-Voting Class X Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series A Non-Voting Class X Preferred Stock shall cease and terminate, excepting only the right to receive certificates (or book entry notations) for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Non-Voting Class X Preferred Stock. In no event shall the Series A Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Securities Purchase Agreement (aTYR PHARMA INC)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A Z Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A Z Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A Z Non-Voting Preferred Stock. In no event shall the Series A Z Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Merger Agreement (Idera Pharmaceuticals, Inc.)

Status as Stockholder. Upon each Conversion Date, (i) the shares of Series A B Non-Voting Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series A B Non-Voting Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series A B Non-Voting Preferred Stock. In no event shall the Series A B Non-Voting Preferred Stock convert into shares of Common Stock prior to the Stockholder Approval.

Appears in 1 contract

Sources: Agreement and Plan of Merger (Galera Therapeutics, Inc.)